entertainment -WSS

entertainment

author：fashion 2025-10-08 16:06:30 - browse：65

Hospital power in DC — Mike Reddy for STAT

WASHINGTON — Democrats unilaterally drove major reforms to the health insurance and the pharmaceutical industries without a single Republican vote in recent years. But hospitals may be a health care giant they’re unable to confront alone.

Unlike Republicans, Democrats have seized on lowering health care costs as a politically winning issue in one election cycle after another. They have campaigned on passing health insurance reform, and then protecting it. And after 20 years, they finally delivered on a promise to empower the federal government to lower drug prices in 2022.

But the remaining elephant in the room is hospital costs, which make up the biggest share of U.S. health care spending. And Democratic leaders in Congress have shown this year that they are unable to agree on even the most incremental steps toward addressing the cost of hospital care.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： The biotech scorecard for Q1: 17 stock

WSS

The cancer stories no one wants to hear

'Null' research findings aren't empty of meaning. Let's publish them

'Null' research findings aren't empty of meaning. Let's publish them

Who is Jack Smith, the special counsel overseeing the DOJ's Trump probes?

Late stage cancers on the rise after pandemic delayed screenings

When waiting feels immoral: Empathy in the emergency department

knowledge

entertainment

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

J&J to buy cancer drug developer Ambrx Biopharma

As demand for Covid shots wanes, Moderna seeks its next success

The cancer stories no one wants to hear

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Alnylam reports growth in sales of rare disease treatments

How to save PrEP access — and even expand it

H.R. 3 is the wrong path to lower drug costs

George Santos makes 1st court appearance after pleading not guilty to 13 counts

FDA approves Sage Therapeutics’ rapid

Wikipedia

3 trends to watch in health tech's hiring outlook for 2024

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

White House finalizes ITC's import ban of latest Apple Watches

Medicare slashes safety net hospital payments by nearly $1 billion

2 officers injured in shooting in Orlando, police say

A single drug, study failures leave Anavex with nothing but cash

explore

hotspot

hotspot

focus